Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gallimore

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
BMC Biochemistry|December 20, 2018
Soluble expression of recombinant midgut zymogen (native propeptide) proteases from the Aedes aegypti Mosquito Utilizing E. coli as a hostJames T Nguyen, Jonathan Fong, Daniel Fong, et al.
Plos Pathogens|April 5, 2008
Interleukin-6 is crucial for recall of influenza-specific memory CD4 T cellsMaria Paula Longhi, Kate Wright, Sarah N Lauder, et al.
Cell Reports Methods|December 3, 2025
OSCAR is an online ML-powered tool for organoid cell counting using bright-field imagesStephanie E A Burnell, Lorenzo Capitani, Chloe A Harris, et al.
Immunology|February 27, 2021
Pouring petrol on the flames: Using oncolytic virotherapies to enhance tumour immunogenicityAlicia Teijeira Crespo, Stephanie Burnell, Lorenzo Capitani, et al.
Cancer Immunology, Immunotherapy : CII|December 18, 2025
Stereotactic ablative radiotherapy-driven immunosuppression is associated with poorer progression-free survival in cancer patientsJessica Oliver, Hannah Reed, Lorenzo Capitani, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 18, 2012
The death receptor 3/TL1A pathway is essential for efficient development of antiviral CD4⁺ and CD8⁺ T-cell immunityJason P Twohig, Morgan Marsden, Simone M Cuff, et al.
European Journal of Immunology|June 2, 2012
Rapid early innate control of hepatitis C virus during IFN-α treatment compromises adaptive CD4+ T-cell immunityTom Pembroke, Ian Rees, Kathleen Gallagher, et al.
Cell Reports|July 20, 2023
Structural definition of HLA class II-presented SARS-CoV-2 epitopes reveals a mechanism to escape pre-existing CD4<sup>+</sup> T cell immunityYuan Chen, Georgina H Mason, D Oliver Scourfield, et al.
Oxford Open Immunology|May 20, 2022
Neutrophilia, lymphopenia and myeloid dysfunction: a living review of the quantitative changes to innate and adaptive immune cells which define COVID-19 pathologyAmy S Codd, Stephanie J Hanna, Ewoud B Compeer, et al.
Plos One|January 6, 2007
CD4+CD25+FOXP3+ regulatory T cells suppress anti-tumor immune responses in patients with colorectal cancerSarah L Clarke, Gareth J Betts, Andrea Plant, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
BMC Biochemistry|December 20, 2018
Soluble expression of recombinant midgut zymogen (native propeptide) proteases from the Aedes aegypti Mosquito Utilizing E. coli as a hostJames T Nguyen, Jonathan Fong, Daniel Fong, et al.
Plos Pathogens|April 5, 2008
Interleukin-6 is crucial for recall of influenza-specific memory CD4 T cellsMaria Paula Longhi, Kate Wright, Sarah N Lauder, et al.
Cell Reports Methods|December 3, 2025
OSCAR is an online ML-powered tool for organoid cell counting using bright-field imagesStephanie E A Burnell, Lorenzo Capitani, Chloe A Harris, et al.
Immunology|February 27, 2021
Pouring petrol on the flames: Using oncolytic virotherapies to enhance tumour immunogenicityAlicia Teijeira Crespo, Stephanie Burnell, Lorenzo Capitani, et al.
Cancer Immunology, Immunotherapy : CII|December 18, 2025
Stereotactic ablative radiotherapy-driven immunosuppression is associated with poorer progression-free survival in cancer patientsJessica Oliver, Hannah Reed, Lorenzo Capitani, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 18, 2012
The death receptor 3/TL1A pathway is essential for efficient development of antiviral CD4⁺ and CD8⁺ T-cell immunityJason P Twohig, Morgan Marsden, Simone M Cuff, et al.
European Journal of Immunology|June 2, 2012
Rapid early innate control of hepatitis C virus during IFN-α treatment compromises adaptive CD4+ T-cell immunityTom Pembroke, Ian Rees, Kathleen Gallagher, et al.
Cell Reports|July 20, 2023
Structural definition of HLA class II-presented SARS-CoV-2 epitopes reveals a mechanism to escape pre-existing CD4<sup>+</sup> T cell immunityYuan Chen, Georgina H Mason, D Oliver Scourfield, et al.
Oxford Open Immunology|May 20, 2022
Neutrophilia, lymphopenia and myeloid dysfunction: a living review of the quantitative changes to innate and adaptive immune cells which define COVID-19 pathologyAmy S Codd, Stephanie J Hanna, Ewoud B Compeer, et al.
Plos One|January 6, 2007
CD4+CD25+FOXP3+ regulatory T cells suppress anti-tumor immune responses in patients with colorectal cancerSarah L Clarke, Gareth J Betts, Andrea Plant, et al.
Pageof 6